Hereditary cancer in clinical practice

· 6 papers in corpus
2022
doi:10.1186/s13053-022-00227-z ·PMID:35668475

BRCA1 and BRCA2 mutation carriers face an elevated lifetime risk of developing ovarian cancer. Oral contraceptives have been shown to significantly decrease the risk of ovarian cancer by approximately 50% in this high-risk population. Chang…

2017
doi:10.1186/s13053-017-0066-9 ·PMID:28507641

BackgroundThe tumor spectrum in the Lynch syndrome is well defined, comprising an increased risk of developing colonic and extracolonic malignancies. Muir-Torre syndrome is a variant with a higher risk of skin disease. Patients have been de…

2015
doi:10.1186/s13053-015-0027-0 ·PMID:25649062

A 46-year-old female presents with a pelvic mass and is diagnosed as having a high-grade endometrial stromal sarcoma. During surgery, she is noted to have areas of intussusception of the small bowel secondary to large hamartomatous polyps. …

2015
doi:10.1186/s13053-015-0025-2 ·PMID:25606063

BackgroundOver half the cancer deaths in HNPCC families are due to extra-colonic malignancies that include endometrial and ovarian cancers. The benefits of surveillance for gynecological cancers are not yet proven and there is no consensus …

2007
2004
doi:10.1186/1897-4287-2-2-77 ·PMID:20233474

This paper highlights the need for carriers to be followed up by health professionals who understand the complexities of the BRCA syndrome. A BRCA carrier clinic has been established in London and regular follow up is an essential part of t…